DJ McBride, D Etemadmoghadam, SL Cooke, K Alsop, J George, A Butler, J Cho, D Galappaththige, C Greenman, KD Howarth, KW Lau, CK Ng, K Raine, J Teague, DC Wedge, AO Cancer Study Group, X Caubit, MR Stratton, JD Brenton, PJ Campbell, PA Futreal, DD Bowtell
Journal name: 
J Pathol
Citation info: 
The application of paired-end next generation sequencing approaches has made it possible to systematically characterize rearrangements of the cancer genome to base-pair level. Utilizing this approach, we report the first detailed analysis of ovarian cancer rearrangements, comparing high-grade serous and clear cell cancers, and these histotypes with other solid cancers. Somatic rearrangements were systematically characterized in eight high-grade serous and five clear cell ovarian cancer genomes and we report here the identification of > 600 somatic rearrangements. Recurrent rearrangements of the transcriptional regulator gene, TSHZ3, were found in three of eight serous cases. Comparison to breast, pancreatic and prostate cancer genomes revealed that a subset of ovarian cancers share a marked tandem duplication phenotype with triple-negative breast cancers. The tandem duplication phenotype was not linked to BRCA1/2 mutation, suggesting that other common mechanisms or carcinogenic exposures are operative. High-grade serous cancers arising in women with germline BRCA1 or BRCA2 mutation showed a high frequency of small chromosomal deletions. These findings indicate that BRCA1/2 germline mutation may contribute to widespread structural change and that other undefined mechanism(s), which are potentially shared with triple-negative breast cancer, promote tandem chromosomal duplications that sculpt the ovarian cancer genome.
Research group: 
Brenton Group
E-pub date: 
31 Aug 2012
Users with this publication listed: 
James Brenton